Journal article Open Access

Rethinking Schizophrenia

Insel, Thomas R.

How will we view schizophrenia in 2030? Schizophrenia today is a chronic, frequently disabling mental disorder that affects about one per cent of the world's population. After a century of studying schizophrenia, the cause of the disorder remains unknown. Treatments, especially pharmacological treatments, have been in wide use for nearly half a century, yet there is little evidence that these treatments have substantially improved outcomes for most people with schizophrenia. These current unsatisfactory outcomes may change as we approach schizophrenia as a neurodevelopmental disorder with psychosis as a late, potentially preventable stage of the illness. This 'rethinking' of schizophrenia as a neurodevelopmental disorder, which is profoundly different from the way we have seen this illness for the past century, yields new hope for prevention and cure over the next two decades.

Files (325.0 kB)
Name Size
article.pdf
md5:5f2ca5cac30dcd2c1d8e5c90fdeba3cf
325.0 kB Download
104
79
views
downloads
Views 104
Downloads 79
Data volume 25.7 MB
Unique views 100
Unique downloads 71

Share

Cite as